<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01965561</url>
  </required_header>
  <id_info>
    <org_study_id>H-13-016</org_study_id>
    <nct_id>NCT01965561</nct_id>
  </id_info>
  <brief_title>Performance of Junctional Tourniquets in Normal Human Volunteers</brief_title>
  <official_title>Performance of Junctional Tourniquets in Normal Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Institute of Surgical Research</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Army Institute of Surgical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Normal human adult volunteers wereused to investigate the performance of medical devices
      intended to stop junctional bleeding on the battlefield.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Four FDA-cleared junctional tourniquets (Combat Ready Clamp (CRoC), Abdominal Aortic and
      Junctional Tourniquet (AAJT), Junctional Emergency Treatment Tool (JETT), and SAM Junctional
      Tourniquet (SJT)) wereassessed in a laboratory on healthy human volunteers. Lower extremity
      pulses were measured in 10 volunteers before and after junctional tourniquet application
      aimed at stopping the distal pulse assessed by Doppler auscultation. Tourniquets were applied
      in a randomized fashion, with 5 min rest periods between each application. Each tourniquet
      was applied to each subject, such that the subjects acted as their own controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness at Stopping Distal Pulse</measure>
    <time_frame>1 min</time_frame>
    <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain During Tourniquet Application</measure>
    <time_frame>1 minute</time_frame>
    <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Hemorrhage</condition>
  <arm_group>
    <arm_group_label>CRoC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Combat Ready Clamp (CRoC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AAJT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Abdominal Aortic and Junctional Tourniquet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>JETT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Junctional Emergency Treatment Tool</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SJT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SAM Junctional Tourniquet</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRoC</intervention_name>
    <description>Use of Combat Ready Clamp (CRoC)</description>
    <arm_group_label>CRoC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AAJT</intervention_name>
    <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
    <arm_group_label>AAJT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JETT</intervention_name>
    <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
    <arm_group_label>JETT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJT</intervention_name>
    <description>Use of SAM Junctional Tourniquet (SJT)</description>
    <arm_group_label>SJT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult human volunteers who are recruited, screened, and consent to participate

          -  Ages at least 18 years old to no more than 60 years old (&lt;61) on the date of consent

          -  Male or female

          -  A worker for the US Military or US Government (active duty military, civilian
             employees, contractors)

        Exclusion Criteria:

          -  Active-duty military subjects without their supervisor's permission to participate

          -  Detainees or prisoners

          -  Evidence of major disease of an artery (e.g., artery or vein surgery, atherosclerotic
             disease diagnosis, stroke, peripheral vascular disease or dysfunction such as
             Reynaud's phenomenon, migraine headaches, or cardiovascular disease [uncontrolled
             hypertension, heart attack, or arrhythmias]), active abdominal, inguinal, gluteal, or
             thigh disease, major deformity, or hernias

          -  Pregnancy

          -  Contracted employees to the US Military or US Government without contractual
             permission to participate in the research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John F Kragh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>United States Army Institute of Surgical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>United States Army Institute of Surgical Research</name>
      <address>
        <city>Forts Sam Houston</city>
        <state>Texas</state>
        <zip>78234-7767</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2013</study_first_submitted>
  <study_first_submitted_qc>October 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2013</study_first_posted>
  <results_first_submitted>September 1, 2015</results_first_submitted>
  <results_first_submitted_qc>September 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 7, 2015</results_first_posted>
  <last_update_submitted>November 14, 2017</last_update_submitted>
  <last_update_submitted_qc>November 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>United States Army Institute of Surgical Research</investigator_affiliation>
    <investigator_full_name>John F. Kragh, Jr, MD</investigator_full_name>
    <investigator_title>Orthopedic Surgeon, Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat. Rest = 5 minutes. SJT is belt with discs that inflate. JETT is belt with pads that screw down. AAT is a bladder within a belt. CRC is a vice.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Healthy human volunteers</population>
      <group_list>
        <group group_id="B1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat
Rest = 5 minutes. SJT is belt with discs that inflate. JETT is belt with pads that screw down. AAT is an bladder within a belt. CRC is a vice.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age of healthy human volunteers</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" lower_limit="42" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain</title>
          <description>Pain level on Visual Analog Scale (0 mm = no pain, 100 mm = maximum pain)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness at Stopping Distal Pulse</title>
        <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
        <time_frame>1 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CRoC</title>
            <description>Use of Combat Ready Clamp (CRoC)</description>
          </group>
          <group group_id="O2">
            <title>AAJT</title>
            <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
          </group>
          <group group_id="O3">
            <title>JETT</title>
            <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
          </group>
          <group group_id="O4">
            <title>SJT Tourniquet</title>
            <description>SAM Junctional Tourniquet (SJT)</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness at Stopping Distal Pulse</title>
          <description>Percentage of participants whose distal pulse ceased within 1 minute of junctional tourniquet application.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="83"/>
                    <measurement group_id="O4" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain During Tourniquet Application</title>
        <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
        <time_frame>1 minute</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CRoC</title>
            <description>Use of Combat Ready Clamp (CRoC)</description>
          </group>
          <group group_id="O2">
            <title>AAJT</title>
            <description>Use of Abdominal Aortic and Junctional Tourniquet (AAJT)</description>
          </group>
          <group group_id="O3">
            <title>JETT</title>
            <description>Use of Junctional Emergency Treatment Tool (JETT)</description>
          </group>
          <group group_id="O4">
            <title>SJT Tourniquet</title>
            <description>SAM Junctional Tourniquet (SJT)</description>
          </group>
        </group_list>
        <measure>
          <title>Pain During Tourniquet Application</title>
          <description>Pain during tourniquet application as measured on a visual analog scale (VAS). The pain scale was a 100-mm-long line on a piece of paper. The subject made a cross mark on the line, which went from the left limit (0 mm) at no pain to the right limit (100 mm) at very severe pain.</description>
          <units>mm on VAS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" spread="23"/>
                    <measurement group_id="O2" value="76" spread="14"/>
                    <measurement group_id="O3" value="45" spread="40"/>
                    <measurement group_id="O4" value="43" spread="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Junctional Tourniquet Use</title>
          <description>Junctional tourniquet use followed by rest, repeat.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Kragh, MD</name_or_title>
      <organization>USAISR</organization>
      <phone>210.539.2210</phone>
      <email>john.f.kragh.civ@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

